Long-Term Outcomes of Bovine versus Porcine Mitral Valve Replacement: A Multicenter Analysis.
Publication/Presentation Date
1-1-2023
Abstract
INTRODUCTION: Recent national guidelines recommending mitral valve replacement (MVR) for severe secondary mitral regurgitation have resulted in an increased utilization of mitral bioprosthesis. There is a paucity of data on how longitudinal clinical outcomes vary by prosthesis type. We examined long-term survival and risk of reoperation between patients having bovine vs. porcine MVR.
RESULTS: In the overall cohort, patients receiving porcine valves were more likely to have diabetes (19% bovine vs. 29% porcine;
CONCLUSIONS: In this multicenter analysis of patients undergoing bioprosthetic MVR, there was no difference in perioperative complications and risk of reoperation of long-term survival after matching.
Volume
2023
First Page
2111843
Last Page
2111843
ISSN
2090-8016
Published In/Presented At
Broadwin, M., Ramkumar, N., Malenka, D. J., Quinn, R. D., Ross, C. S., Hirashima, F., Klemperer, J. D., Kramer, R. S., Sardella, G. L., Westbrook, B., Discipio, A. W., Iribarne, A., & Robich, M. P. (2023). Long-Term Outcomes of Bovine versus Porcine Mitral Valve Replacement: A Multicenter Analysis. Cardiology research and practice, 2023, 2111843. https://doi.org/10.1155/2023/2111843
Disciplines
Medicine and Health Sciences
PubMedID
37426448
Department(s)
Department of Surgery, Department of Surgery Residents
Document Type
Article